AYR: Analysis & Opinions

  1. Bayer to Snap Up Teva Unit in the US - Analyst Blog

    September 17, 2012
    In a bid to diversify its business and expand its animal health business, the HealthCare unit of Bayer (BAYRY) inked ...
  2. Perrigo Eyes Pet Care Market - Analyst Blog

    September 17, 2012
    In a bid to diversify its business into the pet care space, Perrigo Company (PRGO) inked a deal to buy substantially ...
  3. Celsion Progresses with ThermoDox - Analyst Blog

    September 17, 2012
    Celsion Corporation (CLSN) recently announced that the independent Data Monitoring Committee (DMC) completed its ...
  4. sNDA Resubmitted for Bayer/JNJ drug - Analyst Blog

    September 10, 2012
    Johnson & Johnson's (JNJ) Janssen Research and Development unit recently responded to the complete response letter ...
  5. Sigma Inks Deal with AB Sciex - Analyst Blog

    September 10, 2012
    Sigma-Aldrich Corporation (SIAL) announced the signing of an agreement with AB Sciex to distribute its portfolio ...
  6. EC Approves Pfizer's Inlyta - Analyst Blog

    September 05, 2012
    Pfizer Inc. (PFE) recently announced European Commission (EC) approval of its renal cell cancer drug, Inlyta ...
  7. Bayer Seeks Regorafenib Approval - Analyst Blog

    September 05, 2012
    The HealthCare unit of Bayer (BAYRY) recently submitted a new drug application (NDA) with the US Food and Drug ...
  8. Sanofi's Lemtrada US Filing Update - Analyst Blog

    August 28, 2012
    Sanofi's (SNY) subsidiary, Genzyme, recently announced that the US Food and Drug Administration (FDA) has issued a ...
  9. Sigma-Aldrich Extends Materia Deal - Analyst Blog

    August 22, 2012
    Global lab chemical and life sciences company Sigma-Aldrich Corporation (SIAL) announced an extension of its ...
  10. Onyx Loss up on Wider Costs - Analyst Blog

    August 08, 2012
    Onyx Pharmaceuticals Inc. (ONXX) reported second quarter 2012 loss per share of 85 cents, wider than the Zacks ...
  11. Revenues Rise at Bayer, Guides up - Analyst Blog

    August 02, 2012
    Bayer's (BAYRY) earnings per share during the second quarter of 2012 came in at ¬1.47 (approx $1.89) compared with ...
  12. Regeneron Tops, Lifts Eylea View - Analyst Blog

    July 26, 2012
    Regeneron Pharmaceuticals Inc.'s (REGN) second quarter 2012 earnings (excluding special items but including ...
  13. Sigma-Aldrich EPS Meets, Cuts View - Analyst Blog

    July 24, 2012
    Global lab chemical and life sciences company Sigma-Aldrich Corporation (SIAL) posted adjusted earnings of 97 cents ...
  14. Earnings Preview: Sigma-Aldrich - Analyst Blog

    July 23, 2012
    Sigma-Aldrich Corporation (SIAL) is slated to report its second-quarter 2012 results before the market opens on ...
  15. Survival of the Fittest! - Investment Ideas

    July 20, 2012
    Earlier this month I spent a week camping deep in the Southern Indiana woods. With daytime temps between 90-105 and ...
  16. Aircastle Ltd. - Value

    July 20, 2012
    Aircastle Limited (AYR) has delivered positive earnings surprises in four out of the last five quarters, supported ...
  17. Alnylam Inks Oncology Deal - Analyst Blog

    July 13, 2012
    Recently, Alnylam Pharmaceuticals Inc. (ALNY) announced that it has inked a deal with Ascletis Pharmaceuticals, to ...
  18. Speedy Review for Bayer/JNJ Drug - Analyst Blog

    July 11, 2012
    Bayer (BAYRY) and partner, Johnson & Johnson's (JNJ) Janssen Research and Development unit, recently announced that ...
  19. Bayer in Expansion Mode - Analyst Blog

    July 05, 2012
    In a bid to strengthen its presence in the fruits and vegetables market, the CropScience unit of  Bayer (BAYRY) ...
  20. Priority Review for Bayer/Onyx - Analyst Blog

    June 29, 2012
    Bayer's (BAYRY) HealthCare unit and Onyx Pharmaceuticals (ONXX) recently announced that they have received priority ...
Marketplace
Trading Center